|
|
Volumn 19, Issue 3, 2001, Pages 212-213
|
|
Integrated antifungal drug discovery in Candida albicans: A combination of molecular biology and conventional drug screening promises to expedite the identification of compounds against fungal diseases
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIFUNGAL AGENT;
COMPLEMENTARY RNA;
CANDIDA ALBICANS;
DATA BASE;
DRUG EFFECT;
DRUG SCREENING;
ESSENTIAL GENE;
FUNGAL GENE;
GENE LIBRARY;
GENETIC TRANSFORMATION;
GENETICS;
GROWTH, DEVELOPMENT AND AGING;
METHODOLOGY;
MOLECULAR CLONING;
NOTE;
PATHOGENICITY;
PROMOTER REGION;
SACCHAROMYCES CEREVISIAE;
ANTIFUNGAL AGENTS;
CANDIDA ALBICANS;
CLONING, MOLECULAR;
DATABASES;
DRUG EVALUATION, PRECLINICAL;
GENE LIBRARY;
GENES, ESSENTIAL;
GENES, FUNGAL;
PROMOTER REGIONS (GENETICS);
RNA, ANTISENSE;
SACCHAROMYCES CEREVISIAE;
TRANSFORMATION, GENETIC;
|
|
EID: 0035289342
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/85634 Document Type: Article |
|
Times cited : (3)
|
|
References (7)
|
